Home

Slide MORE RESEARCH BETTER HEALTH ENCOURAGE KNOWLEDGE OUR SCIENCE YOUR FUTURE

Highlights

stay up to date

Slide A non-progressive congenital ataxia (NPCA) phenotype caused by b-III spectrin (SPTBN2) mutations has emerged Slide Slide Las fundaciones de investigación de Sanidad participan en un proyecto de Medicina Predictiva y Ciencia de Datos con más de 100 instituciones. 19/01/2021 Slide El CIPF de Valencia desarrolla un test de saliva para detectar el SARS-CoV-2. 19/01/2021 Slide Disparate Response to Caloric Restriction Diet with Fibre Supplementation in Women and Men Slide Slide Slide Slide

Latest News

Updates on our activities

More News

MOLECULAR BASIS OF HUMAN DISEASE The programme Molecular Basis of Human Disease is focused on the research of the causes and human diseases with emphasis in rare diseases, metabolic mechanisms of several diseases and cancer. The overarching goal is to generate knowledge that will contribute LEARN MORE NEUROINFLAMMATION AND NEUROLOGICAL IMPAIRMENT The Neuroinflammation and Neurological Impairment program performs basic and translational research into the mechanisms, diagnosis, and treatment of neurological (cognitive, motor, functional, and sleep-related) impairment in different pathological contexts. LEARN MORE BIOINFORMATICS AND COMPUTATIONAL BIOLOGY Has a clear orientation to the clinical practice and a translational character. Our computational skills puts us in a privileged position regarding other disciplines when we have to manage data resulting from different omics techniques LEARN MORE ADVANCED
THERAPIES The objective of the Advanced Therapies Programme is the development of new diagnostic and therapeutic approaches for high-impact public health problems through the application of both pharmacology (Including HTS approaches and Nanomedicine), cellular therapies, and their combination LEARN MORE
DISCOVER OUR RESEARCH PROGRAMS

upcoming events

Save the date!

More Events

27apr19:3021:00CONFERENCIA. CÉLULAS MADRE Y ENVEJECIMIENTO: ¿PODEMOS MANIPULAR ESTE PROCESO?19:30 - 21:00 Event Type :SEMINAR

More Events

april, 2021

27apr19:3021:00CONFERENCIA. CÉLULAS MADRE Y ENVEJECIMIENTO: ¿PODEMOS MANIPULAR ESTE PROCESO?19:30 - 21:00 Event Type :SEMINAR

upcoming events

take note

More events

lectures

sharing knowledge

DSC_0712

Dr. Michèle Studer

14.02.2020
Genetics, activity and patterning in a mouse model of a recently described neurodevelopmental brain disorder
DSC_0707

Dr. Elfride de Baere

17.01.2020
Integrated omics to understand missing heritability in inherited retinal diseases causing blindness

lectures

SHARING knowledge

DSC_0712

Dr. Michèle Studer

14.02.2020
Genetics, activity and patterning in a mouse model of a recently described neurodevelopmental brain disorder
DSC_0707

Dr. Elfride de Baere

17.01.2020
Integrated omics to understand missing heritability in inherited retinal diseases causing blindness
More Lectures

DISCOVER

meet our scientists

CARMEN ESPINOS GENETICS AND GENOMICS OF NEUROMUSCULAR AND
NEURODEGENERATIVE DISORDERS CARMEN ESPINÓS GO TO GROUP REGINA RODRIGO PATHOPHYSIOLOGY AND THERAPY FOR VISION DISORDERS REGINA RODRIGO GO TO GROUP DEBORAH MOLECUAR NEUROENDOCRINOLOGY DEBORAH J. BURKS GO TO GROUP ENRIC MOLECULAR AND CELLULAR IMMUNOLOGY ENRIC ESPLUGUES GO TO GROUP ROSA FARRAS ONCOGENIC SIGNALLING ROSA FARRÁS GO TO GROUP IBORRA BIOLOGICAL NOISE AND CELL PLASTICITY FRANCISCO JOSÉ IBORRA GO TO GROUP ISABEL DEL PINO NEURAL PLASTICITY ISABEL DEL PINO GO TO GROUP PIETRO CORTICAL CIRCUITS IN HEALTH AND DISEASE PIETRO FAZZARI GO TO GROUP FELIPO NEUROBIOLOGY VICENTE FELIPO GO TO GROUP CHELO GUERRI MOLECULAR AND CELULAR PATHOLOGY OF ALCOHOL CONSUELO GUERRI GO TO GROUP DUNJA RETINAL DEGENERATION DUNJA LUKOVIC GO TO GROUP PACO GARCIA BIOINFORMATICS AND BIOSTATISTICS UNIT FRANCISCO GARCÍA GO TO GROUP SLAVEN STEM CELL THERAPIES IN NEURODEGENERATIVE DISEASES SLAVEN ERGEG GO TO GROUP VICKY NEURONAL AND TISSUE REGENERATION VICTORIA MORENO GO TO GROUP MAR TARGETED THERAPIES ON
CANCER AND INFLAMMATION MAR ORZAEZ GO TO GROUP MJ VICENT POLYMER THERAPEUTICS Mª JESÚS VICENT GO TO GROUP LUKE NOON METABOLIC GROWTH SIGNALS
AND REGERENATIVE MEDICINE LUKE A. NOON GO TO GROUP ALFONSO BENITEZ HOST-MICROBE INTERACTIONS IN METABOLIC HEALTH ALFONSO BENÍTEZ GO TO GROUP

KNOW US BETTER

VIDEO SELECTION

Slide Background Un honor rebre hui al @CIPFciencia al vicepresident de la Generalitat Valenciana @rmartinezdalmau @GVAvicepres2n https://t.co/dEg18sNuPl 05.03.2021 11:45 @CIPFciencia 2 8 Slide Background Compartimos este evento de @STOP_FMF que se celebra el próximo sábado 6 de marzo @XFragil_CV @AMESMIASTENIA https://t.co/qnlJUhSA7B 03.03.2021 14:54 @CIPFciencia 1 3 Slide Background RT @BecarioslaCaixa: 👏 👏 ¡Enhorabuena al #BecariosFundlaCaixa David Palmero!

El biotecnólogo ha sido nombrado ganador de la XVI edición d… 02.03.2021 16:51 @CIPFciencia 1 0 Slide Background ¿Qué es la PCR? ¿Para qué se utiliza? https://t.co/ABuw5DKliM Vídeo explicativo de las numerosas aplicaciones de la PCR, gracias a la colaboración de Salvador Meseguer, Amparo Galán y Laura Ramírez #MásInvestigación #MejorSalud 02.03.2021 12:20 @CIPFciencia 1 2 Slide Background Inscripción abierta del 1 al 15 de marzo, dirigida a estudiantes de #FPDual @DualizaBankia https://t.co/VQoSolWyBz 01.03.2021 13:33 @CIPFciencia 1 3 Slide Background RT @generalitat: 🏥🔎 Programa Valencià d'Investigació Vacunal #COVID19 sobre el procés d'immunització

✅ Un projecte coordinat entre la xarx… 01.03.2021 13:26 @CIPFciencia 17 0 Slide Background RT @bernardgaspar14: 🔬🫁 👨‍🔬Si tienes un proyecto de investigación sobre detección, diagnóstico precoz o cribado de #cáncerdepulmón 👇

🔴 #Lu… 01.03.2021 10:58 @CIPFciencia 13 0 Slide Background RT @anabarcelochico: La investigación es fundamental, es la esperanza para quienes padecen Enfermedades Raras. 28.02.2021 11:13 @CIPFciencia 23 0 Slide Background RT @GVAsanitat: 📌 Desde @GVAsanitat nos sumamos hoy 2️⃣8️⃣ febrero a la conmemoración del Día Mundial de las #EnfermedadesRaras

✅ La #Com… 28.02.2021 08:44 @CIPFciencia 65 0 Slide Background El Lab. de Enfermedades Raras Neurodegenerativas que dirige Carmen Espinós en @CIPFciencia, en colaboración con Sergio Aguilera-Albesa @navarrabiomed, describen una nueva forma de ataxia congénita no progresiva causada por mutaciones en el gen β-III espectrina #RareDiseaseDay2021 https://t.co/CjAWQHy3aX 28.02.2021 07:50 @CIPFciencia 3 10